Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $22.6000 (2.68%) ($22.0000 - $22.6100) on Wed. Jan. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.74% (three month average) | RSI | 27 | Latest Price | $22.6000(2.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -7.5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) ARKG(48%) XBI(48%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -1.87% in a week (0% probabilities). VIXM(-29%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.87% (StdDev 3.74%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
1 - 5 Day Possible Target | $8.69(-61.55%) | Resistance Level | $24.46 | 5 Day Moving Average | $22.24(1.62%) | 10 Day Moving Average | $22.89(-1.27%) | 20 Day Moving Average | $24.46(-7.6%) | To recent high | -23.2% | To recent low | 10.5% | Market Cap | $3.309b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |